Healwell AI (AIDX.TO) Stock Analysis & Winston Score
Healwell AI is a Canadian healthcare technology company that uses artificial intelligence to help doctors find patients who may have serious diseases before those diseases get worse. Its main products are AI-powered software tools that scan electronic health records to flag patients at risk for conditions like rare diseases and cancer. The company sells primarily to primary care clinics and physician networks across Canada. Healwell makes money by licensing its software to healthcare providers, which generates recurring subscription-style revenue. It operates mainly in Canada and is a small-cap company with a market capitalization around $300 million. The company has also grown through acquisitions of other health data and analytics businesses, which gives it a broader set of tools and customer relationships. Because it is still unprofitable with a negative operating margin, the key risk is whether it can scale its revenue fast enough to cover its costs before needing to raise more capital.
Winston Score: 28/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (6/30)
- Growth: Mixed (8/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
